{
  "company": {
    "name": "iOMx Therapeutics",
    "website": "https://iomx.com/",
    "record": "https://startuphistory.org/c/iomx.com"
  },
  "status": null,
  "history_since": "2008-05-16T04:10:53.000Z",
  "baseline": {
    "snapshot_id": "06f3bf701bcadf7a946b65bd41a850f0c1b6d2a76376ab3ab5bc7072bca4e128",
    "observed_at": "2008-05-16T04:10:53.000Z",
    "headline": null,
    "description": "Free website content & content management System cms, enterprise open source content management systems for web site content management solutions.",
    "evidence": "https://web.archive.org/web/20080516041053/http://www.iomx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:26:21.192Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:26:21.192Z",
      "variants": [
        {
          "headline": "Developing next-generation targeted cancer immunotherapy treatments",
          "subhead": "We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down, immune-break",
          "observed_at": "2022-07-27T05:49:05.000Z",
          "evidence": "https://web.archive.org/web/20220727054905/https://iomx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing next-generation targeted cancer immunotherapy treatments",
          "subhead": "We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down, immune-break",
          "observed_at": "2023-08-22T16:34:43.000Z",
          "evidence": "https://web.archive.org/web/20230822163443/https://iomx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing next-generation targeted cancer immunotherapy treatments",
          "subhead": "We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down, immune-break",
          "observed_at": "2025-01-08T21:19:07.000Z",
          "evidence": "https://web.archive.org/web/20250108211907/https://iomx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The next generation",
          "subhead": "See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in advancing cancer care.",
          "observed_at": "2026-01-18T14:13:03.000Z",
          "evidence": "https://web.archive.org/web/20260118141303/https://www.iomx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The next generation",
          "subhead": "See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in advancing cancer care.",
          "observed_at": "2026-11-06T17:26:21.192Z",
          "evidence": "https://www.iomx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "The next generation",
      "subhead": "See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in advancing cancer care.",
      "from": "2022-07-27T05:49:05.000Z",
      "to": "2026-11-06T17:26:21.192Z",
      "captures": 5,
      "evidence": "https://www.iomx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2022-07-27T05:49:05.000Z",
          "to": "2026-11-06T17:26:21.192Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ac1327ec4df2946db7818504f32ce0ef3c52074529251050210118363c33a172:04303e09bc106939cdc0728e9ebe9face5d3557ce525bf4288d75ae2f67647b4:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20110713052346/http://www.iomx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2011-07-13T05:23:46.000Z",
        "to": "2022-07-27T05:49:05.000Z"
      },
      "evidence": "https://web.archive.org/web/20220727054905/https://iomx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-48f7046c4c44abcace9b305fd44d11354fdf1d35c5b02ad5b3210ca2b237c9d1:98a7185960478dd4797f9dfd0958fd7264c13d085bf17f378b306cb6856eff68:headline:bac19133eef2fec1",
      "before_evidence": "https://web.archive.org/web/20250108211907/https://iomx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Developing next-generation targeted cancer immunotherapy treatments” to “The next generation”.",
      "between": {
        "from": "2025-01-08T21:19:07.000Z",
        "to": "2026-01-18T14:13:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20260118141303/https://www.iomx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-48f7046c4c44abcace9b305fd44d11354fdf1d35c5b02ad5b3210ca2b237c9d1:98a7185960478dd4797f9dfd0958fd7264c13d085bf17f378b306cb6856eff68:investors:0263a81dea1bca82",
      "before_evidence": "https://web.archive.org/web/20250108211907/https://iomx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: Sofinnova Partners, Mig Fonds, Wellington Partners, M Ventures and Arvantis Group.",
      "between": {
        "from": "2025-01-08T21:19:07.000Z",
        "to": "2026-01-18T14:13:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20260118141303/https://www.iomx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “iOMx Therapeutics” company record, https://startuphistory.org/c/iomx.com"
}